Oracle Co. (NYSE:ORCL) Position Increased by US Bancorp DE

US Bancorp DE increased its position in shares of Oracle Co. (NYSE:ORCL) by 9.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,509,227 shares of the enterprise software provider’s stock after acquiring an additional 130,150 shares during the period. US Bancorp DE owned about 0.05% of Oracle worth $159,118,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Orion Capital Management LLC purchased a new stake in shares of Oracle during the third quarter worth $25,000. Ritter Daniher Financial Advisory LLC DE increased its stake in shares of Oracle by 298.4% in the third quarter. Ritter Daniher Financial Advisory LLC DE now owns 243 shares of the enterprise software provider’s stock worth $26,000 after purchasing an additional 182 shares during the period. Spartan Planning & Wealth Management bought a new position in shares of Oracle in the third quarter worth about $27,000. Tidemark LLC bought a new position in shares of Oracle in the fourth quarter worth about $29,000. Finally, Nordwand Advisors LLC bought a new position in shares of Oracle in the fourth quarter worth about $30,000. 42.44% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director George H. Conrades sold 25,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 1st. The shares were sold at an average price of $116.13, for a total value of $2,903,250.00. Following the completion of the transaction, the director now owns 17,836 shares in the company, valued at approximately $2,071,294.68. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Oracle news, CEO Safra Catz sold 790,000 shares of the company’s stock in a transaction on Tuesday, March 26th. The shares were sold at an average price of $126.54, for a total transaction of $99,966,600.00. Following the completion of the sale, the chief executive officer now owns 1,118,592 shares in the company, valued at approximately $141,546,631.68. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director George H. Conrades sold 25,000 shares of the company’s stock in a transaction on Wednesday, May 1st. The shares were sold at an average price of $116.13, for a total transaction of $2,903,250.00. Following the sale, the director now owns 17,836 shares of the company’s stock, valued at approximately $2,071,294.68. The disclosure for this sale can be found here. Insiders sold 880,000 shares of company stock worth $110,488,150 in the last quarter. Insiders own 42.80% of the company’s stock.

Wall Street Analyst Weigh In

ORCL has been the topic of a number of recent analyst reports. The Goldman Sachs Group lifted their price objective on Oracle from $115.00 to $130.00 and gave the stock a “neutral” rating in a research note on Wednesday, March 13th. KeyCorp initiated coverage on Oracle in a research report on Thursday, March 21st. They set an “overweight” rating and a $150.00 target price on the stock. BMO Capital Markets lifted their target price on Oracle from $126.00 to $142.00 and gave the stock a “market perform” rating in a research report on Tuesday, March 12th. William Blair raised Oracle from a “market perform” rating to an “outperform” rating in a research report on Tuesday, March 12th. Finally, HSBC lifted their target price on Oracle from $144.00 to $155.00 and gave the stock a “buy” rating in a research report on Wednesday, March 13th. Ten investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $130.76.

Oracle Price Performance

Shares of ORCL traded down $0.92 on Thursday, hitting $123.68. The company’s stock had a trading volume of 2,988,532 shares, compared to its average volume of 7,977,314. The company has a market capitalization of $339.93 billion, a PE ratio of 32.88, a PEG ratio of 2.90 and a beta of 1.03. The company has a debt-to-equity ratio of 13.34, a current ratio of 0.85 and a quick ratio of 0.85. Oracle Co. has a fifty-two week low of $97.29 and a fifty-two week high of $132.77. The company has a 50 day moving average price of $121.40 and a 200 day moving average price of $114.83.

Oracle (NYSE:ORCL) last posted its quarterly earnings data on Monday, March 11th. The enterprise software provider reported $1.41 earnings per share for the quarter, topping the consensus estimate of $1.37 by $0.04. Oracle had a net margin of 20.27% and a return on equity of 336.11%. The firm had revenue of $13.28 billion during the quarter, compared to analysts’ expectations of $13.29 billion. During the same quarter in the previous year, the company posted $0.96 EPS. Oracle’s revenue was up 7.1% on a year-over-year basis. On average, research analysts anticipate that Oracle Co. will post 4.44 earnings per share for the current fiscal year.

Oracle Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, April 24th. Investors of record on Wednesday, April 10th were given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 1.29%. The ex-dividend date was Tuesday, April 9th. Oracle’s dividend payout ratio (DPR) is presently 42.22%.

Oracle Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.